Published: 27 November, 2017
Senior Regulatory Scientist, Siobhan Murphy, explores the regulatory background of in-situ generated active substances and considers why this is shaping up to be one of the more challenging areas of the BPR in the latest edition of Speciality Chemicals.
When the Biocidal Products Regulation (BPR) entered into force, it bought with it a number of hurdles for industry and authorities. The article discusses the regulatory background, how to meet regulatory obligations and what needs to be done moving forward in helping to address the problem of reduced numbers of ‘standard’ active substances available on the market.
For further details on in situ generated active substances and the challenges of the BPR, contact us on +44(0)1524 510278 or email email@example.com.